Opportunity ID: 332473

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HG-21-006
Funding Opportunity Title: Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.172 — Human Genome Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 30, 2021
Last Updated Date: Mar 30, 2021
Original Closing Date for Applications: Feb 01, 2023
Current Closing Date for Applications: Feb 01, 2023
Archive Date: Mar 09, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
State governments
Independent school districts
Public housing authorities/Indian housing authorities
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Native American tribal governments (Federally recognized)
Special district governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The National Human Genome Research Institute intends to promote a new initiative by publishing a Request for Applications to solicit R01 applications for research in the area of Transformative Nucleic Acid Sequencing Technology Innovation and Early Development: The purpose of the RFA is to refocus and emphasize NHGRIs investment in nucleic acid sequencing technology on novel technology innovation and early development. This Notice is being provided to allow potential applicants sufficient time to develop effective collaborations and responsive projects. The FOA is expected to be published in the winter of 2021 with an expected application due date in the summer of 2021.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-21-006.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 332473 Full Announcement-RFA-HG-21-006 -> RFA-HG-21-006-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00266250 May 26, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00269874 Oct 28, 2021 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277879 Nov 01, 2022 Feb 01, 2023 View

Package 1

Mandatory forms

332473 RR_SF424_2_0-2.0.pdf

332473 PHS398_CoverPageSupplement_5_0-5.0.pdf

332473 RR_OtherProjectInfo_1_4-1.4.pdf

332473 PerformanceSite_2_0-2.0.pdf

332473 RR_KeyPersonExpanded_2_0-2.0.pdf

332473 PHS398_ResearchPlan_4_0-4.0.pdf

332473 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

332473 RR_Budget_1_4-1.4.pdf

332473 RR_SubawardBudget30_1_4-1.4.pdf

332473 PHS398_ModularBudget_1_2-1.2.pdf

332473 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

332473 RR_SF424_5_0-5.0.pdf

332473 PHS398_CoverPageSupplement_5_0-5.0.pdf

332473 RR_OtherProjectInfo_1_4-1.4.pdf

332473 PerformanceSite_4_0-4.0.pdf

332473 RR_KeyPersonExpanded_4_0-4.0.pdf

332473 PHS398_ResearchPlan_4_0-4.0.pdf

332473 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

332473 RR_Budget_3_0-3.0.pdf

332473 RR_SubawardBudget30_3_0-3.0.pdf

332473 PHS398_ModularBudget_1_2-1.2.pdf

332473 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

332473 RR_SF424_5_0-5.0.pdf

332473 PHS398_CoverPageSupplement_5_0-5.0.pdf

332473 RR_OtherProjectInfo_1_4-1.4.pdf

332473 PerformanceSite_4_0-4.0.pdf

332473 RR_KeyPersonExpanded_4_0-4.0.pdf

332473 PHS398_ResearchPlan_5_0-5.0.pdf

332473 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

332473 RR_Budget_3_0-3.0.pdf

332473 RR_SubawardBudget30_3_0-3.0.pdf

332473 PHS398_ModularBudget_1_2-1.2.pdf

332473 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T20:59:24-05:00

Share This Post, Choose Your Platform!

About the Author: